人民财讯8月27日电，嘉美包装（002969）8月27日晚发布半年报，2025年上半年营收净利双双下滑，其 中营业收入为12.57亿元，同比下降8.73%；净利润1974.16万元，同比下降65.59%。 ...

格隆汇8月27日丨嘉美包装(002969.SZ)公布2025年半年度报告，上半年公司实现营业收入12.57亿元，同 比下降8.73%；归属于上市公司股东的净利润1974.16万元，同比下降65.59%；归属于上市公司股东的扣 除非经常性损益的净利润1625.73万元，同比下降71.81%；基本每股收益0.0207元。 ...

嘉美食品包装（滁州）股份有限公司 2025 年半年度报告全文 嘉美食品包装（滁州）股份有限公司 2025 年半年度报告 2025 年 08 月 1 嘉美食品包装（滁州）股份有限公司 2025 年半年度报告全文 第一节 重要提示、目录和释义 公司董事会、监事会及董事、监事、高级管理人员保证半年度报告内容 的真实、准确、完整，不存在虚假记载、误导性陈述或者重大遗漏，并承担 个别和连带的法律责任。 公司负责人陈民、主管会计工作负责人陈民及会计机构负责人(会计主管 人员)季中华声明：保证本半年度报告中财务报告的真实、准确、完整。 所有董事均已出席了审议本次半年报的董事会会议。 本报告中涉及的未来计划等前瞻性陈述，不构成公司对投资者的实质承 诺，敬请广大投资者注意投资风险。 公司在 2025 年可能面临宏观经济波动及下游行业周期性风险、市场竞争 风险、客户集中风险及毛利率波动的风险等。详见本报告"第三节 管理层讨 论与分析，十、公司面临的风险和应对措施"。 公司计划不派发现金红利，不送红股，不以公积金转增股本。 2 | 第一节 重要提示、目录和释义 . | 2 | | --- | --- | | 第二节 公司简介和主要 ...

证券代码：002969 证券简称：嘉美包装 公告编号：2025-049 债券代码：127042 债券简称：嘉美转债 嘉美食品包装（滁州）股份有限公司 关于股份回购进展情况的公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 一、 回购方案的主要内容 嘉美食品包装（滁州）股份有限公司（以下简称"公司"）于 2024 年 10 月 29 日召开第三届董事会第十一次会议，于 2024 年 11 月 15 日召开 2024 年第二 次临时股东大会，分别审议通过了《关于以集中竞价交易方式回购公司股份方案 的议案》，同意公司使用自有资金或回购专项贷款以集中竞价方式回购部分公司 已发行的人民币普通股（A 股）股票，回购的股份将用于转换公司发行的可转换 为股票的公司债券，回购股份资金总额不低于人民币 7,500 万元（含）且不超过 人民币 15,000 万元（含），回购价格不超过人民币 4.40 元/股（含）。本次回购的 实施期限为自股东大会审议通过之日起 12 个月内。详见公司分别于 2024 年 10 月 31 日 、 2024 年 11 月 18 日 刊 登 在 《 ...

证券代码：002969 证券简称：嘉美包装 公告编号：2025-050 债券代码：127042 债券简称：嘉美转债 嘉美食品包装（滁州）股份有限公司 关于嘉美转债 2025 年付息的公告 7、"嘉美转债"本次付息的债权登记日为 2025 年 8 月 8 日，凡在 2025 年 8 月 8 日（含）前买入并持有本期债券的投资者享有本次派发的利息；2025 年 8 月 8 日卖出本期债券的投资者不享有本次派发的利息。在债权登记日前（包括付 息债权登记日）申请转换成公司股票的可转换公司债券，公司不再向其持有人支 付本计息年度及以后计息年度的利息。 8、下一付息期起息日：2025 年 8 月 9 日 经中国证券监督管理委员会《关于核准嘉美食品包装（滁州）股份有限公司 公开发行可转换公司债券的批复》（证监许可﹝2020﹞2301 号）核准，嘉美食 品包装（滁州）股份有限公司（以下简称"公司"或"嘉美包装"）于 2021 年 8 月 9 日公开发行了 7,500,000 张可转换公司债券（以下简称"可转债"），每张 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有 虚假记载、误导性陈述或重大遗漏。 特别提示 ...

Group 1: Industry Overview - The Chinese packaging industry can be divided into three competitive tiers based on revenue: the first tier includes companies like Yutong Technology, Aorikin, and Hexing Packaging with revenues over 10 billion yuan; the second tier includes Baosteel Packaging, Shengxing Co., and Shandong Pharmaceutical Glass with revenues between 3 billion and 10 billion yuan; the third tier consists of companies like Jinfutec, Xianggang Technology, and Longlide with revenues below 3 billion yuan [1][6] - The industry is characterized by a fragmented market structure, with many small-scale companies lacking innovation capabilities, leading to disordered competition in the low-end market [6][13] - The market concentration in the packaging industry is low, with the top 10 companies (CR10) holding less than 5% market share, indicating a need for further consolidation [6][13] Group 2: Market Segmentation - The packaging industry in China is segmented into glass packaging, paper packaging, plastic packaging, and metal packaging, with leading companies in each category: Shandong Pharmaceutical Glass and Zhengchuan Co. for glass; Wanshun New Materials and Shanying International for paper; Tongchan Lixing and Hongyu Packaging for plastic; and Shengxing Packaging and Jiamei Packaging for metal [4][9] Group 3: Competitive Landscape - The competitive landscape shows that leading companies like Shandong Pharmaceutical Glass and Zhengchuan Co. have extensive business layouts covering regions such as North America, Europe, Japan, and Southeast Asia [8][9] - The majority of packaging companies focus on specific materials, with Shandong Pharmaceutical Glass leading in medicinal glass, while companies like Dashing and Wanshun New Materials dominate the paper packaging sector [10][11] - The industry is experiencing a strong demand growth driven by the increasing consumption of food and beverages, which indirectly boosts the demand for packaging products [14]

Group 1 - The core viewpoint of the news is that companies are actively engaging in share buyback and employee stock ownership plans to enhance investor confidence and align management interests with shareholders [1][2]. - Shenzhen Overseas Chinese Town Holdings Company plans to increase its stake in Huaqiang City A by investing between 111 million and 220 million RMB within six months, currently holding 48.78% of the total shares [1]. - Chengyi Pharmaceutical announced an employee stock ownership plan for 2025, targeting to raise up to 48.2864 million RMB, with a share price set at 5.02 RMB per share, covering up to 228 employees [1][2]. Group 2 - The employee stock ownership plan has performance targets for revenue and net profit from 2025 to 2027, with growth rates set at 30%, 55%, and 85% for revenue, and 35%, 65%, and 100% for net profit [2]. - Several companies have announced plans for share reductions by executives and major shareholders, including Jinzheng Co., which plans to reduce up to 28.8 million shares, equivalent to approximately 568 million RMB [3][4][5]. - The reduction plans are set to commence from July 15, indicating a trend of liquidity events in the market as companies adjust their shareholder structures [7][8].

Core Viewpoint - The article summarizes significant announcements from various listed companies in the Shanghai and Shenzhen stock markets, highlighting changes in control, major asset acquisitions, and performance forecasts for the first half of 2025. Group 1: Control Changes and Stock Suspension - Yangdian Technology is planning a change in control, leading to a stock suspension starting July 14, 2025, for up to 2 trading days [3] - Yuanli Co. is also planning to acquire control of Fujian Tongsheng New Materials Technology, resulting in a stock suspension starting July 14, 2025, for up to 10 trading days [5] - Kanghua Bio is planning a change in control, with stock suspension starting July 14, 2025, for up to 2 trading days [6] - Fuda Alloy is planning to acquire at least 51% of Guangda Electronics, which constitutes a major asset restructuring but will not change the actual controller [7] Group 2: Performance Forecasts - Limin Co. expects a net profit of 260 million to 280 million yuan for H1 2025, a year-on-year increase of 719.25% to 782.27% due to rising sales and prices [9] - Zijin Mining anticipates a net profit of approximately 23.2 billion yuan for H1 2025, a year-on-year increase of about 54% [10] - Chunqiu Electronics forecasts a net profit of 90 million to 110 million yuan for H1 2025, an increase of 236.05% to 310.72% [11] - Jinqilin expects a net profit of around 106 million yuan for H1 2025, a year-on-year increase of 222.36% [12] - Beihua Co. anticipates a net profit of 98 million to 111 million yuan for H1 2025, a year-on-year increase of 182.72% to 220.23% [14] - Guojin Securities expects a net profit of 1.092 billion to 1.137 billion yuan for H1 2025, a year-on-year increase of 140% to 150% [15] - Jiu Yuan Silver Sea forecasts a net profit of 26.49 million to 32.25 million yuan for H1 2025, a year-on-year increase of 130% to 180% [16] - Lankai Technology expects a net profit of 1.1 billion to 1.2 billion yuan for H1 2025, a year-on-year increase of 85.5% to 102.36% [17] - Changcheng Securities anticipates a net profit of 1.335 billion to 1.407 billion yuan for H1 2025, a year-on-year increase of 85% to 95% [18] - Weilan Lithium Core expects a net profit of 300 million to 360 million yuan for H1 2025, a year-on-year increase of 79.29% to 115.15% [19] - Yinlong Co. forecasts a net profit of 161 million to 181 million yuan for H1 2025, a year-on-year increase of 60% to 80% [21] - Aopumai expects a net profit of approximately 37 million yuan for H1 2025, a year-on-year increase of 53.28% [22] - Bailong Dongfang anticipates a net profit of 350 million to 410 million yuan for H1 2025, a year-on-year increase of 50.21% to 75.97% [23] - Shanghai Electric expects a net profit of 1.754 billion to 2.087 billion yuan for H1 2025, a year-on-year increase of 32.18% to 57.27% [24] - Huazhong Securities expects a net profit of 1.035 billion yuan for H1 2025, a year-on-year increase of 44.94% [25] - Bailong Chuangyuan anticipates a net profit of 171 million yuan for H1 2025, a year-on-year increase of 42.68% [26] - Chengyi Pharmaceutical expects a net profit of 107 million to 119 million yuan for H1 2025, a year-on-year increase of 40% to 55% [27] - Jinhai Biological anticipates a net profit of 127 million to 141 million yuan for H1 2025, a year-on-year increase of 40% to 55% [28] - Kanda New Materials expects a net profit of 50 million to 55 million yuan for H1 2025, turning from loss to profit [29] - China Shenhua expects a net profit of 23.6 billion to 25.6 billion yuan for H1 2025, a year-on-year decrease of 8.6% to 15.7% [30] - ST Songfa anticipates a net profit of 580 million to 700 million yuan for H1 2025, turning from loss to profit [31] - Chengxing Co. expects a net profit of 16 million to 23 million yuan for H1 2025, turning from loss to profit [33] - Ningbo Fubon anticipates a net profit of 8 million to 12 million yuan for H1 2025, turning from loss to profit [34] - ST Yundong expects a loss of 100 million to 150 million yuan for H1 2025, worsening from the previous year [35] - Kairuide expects a loss of 15 million to 22 million yuan for H1 2025, turning from profit to loss [36] Group 3: Shareholding Changes - Defu Technology's shareholders plan to reduce their holdings by up to 4.04% [38] - Jinzhen Co.'s shareholders plan to reduce their holdings by up to 3.04% [39] - Shikong Technology's shareholder plans to reduce their holdings by up to 3% [40] - Qilu Bank's shareholder plans to reduce their holdings by up to 1.1% [41] - Zhongci Electronics' shareholder plans to reduce their holdings by up to 1% [42] - Jiamei Packaging's shareholders plan to reduce their holdings by up to 1% [43] - Saike Xide's shareholder plans to reduce their holdings by up to 1% [44] - Gongda High-tech's general manager plans to reduce their holdings by up to 0.3424% [46] - Qingyuan Co.'s shareholder plans to reduce their holdings by up to 273,800 shares [47] Group 4: Major Contracts - Dashijiang expects to win a procurement project worth 122 million yuan [49] - Robotech signed significant daily operational contracts worth approximately 14.18 million USD [50]

Group 1 - The core viewpoint of the articles highlights various companies' shareholder actions, financial forecasts, and market activities, indicating potential investment opportunities and risks in the market [1][2]. Group 2 - Qingyuan Co., Ltd. plans to reduce its shareholding by no more than 1% of the company's total shares [1] - Jiamei Packaging also intends to collectively reduce its shareholding by no more than 1% [1] - ST Dongshi is publicly recruiting investors for restructuring [1] - Hongcheng Convertible Bond will not be forcibly redeemed [1] - Jintian Co., Ltd. expects a net profit of 340 million to 400 million for the first half of 2025, representing a year-on-year increase of 176.66% to 225.48% [1] - Meijin Energy anticipates a loss of 700 million to 480 million for the first half of 2025 [1] - Zhonglu Convertible Bond and Kuitian Convertible Bond will not undergo adjustments [1] - Xizhen Convertible Bond has been listed [1] - Shanda Electric Power and Jiyuan Group are new stocks available for subscription on the Shanghai and Shenzhen exchanges [1] - Southern Universal Data Center REIT (508060) and Southern Runze Technology Data Center REIT (180901) are available for subscription [1]

Corporate Announcements - Yangdian Technology is planning a change in control, leading to a suspension of its stock from July 14, 2025, for up to 2 trading days [3] - Degute is planning to acquire 100% of Haowei Technology through a combination of share issuance and cash payment, with stock resuming trading on July 14, 2025 [4] - Yuanli Co. is planning to acquire control of Fujian Tongsheng New Materials Technology, resulting in a stock suspension starting July 14, 2025, for up to 10 trading days [5] - Kanghua Bio is also planning a change in control, with stock suspension from July 14, 2025, for up to 2 trading days [6] - Fuda Alloy is planning to acquire at least 51% of Guangda Electronics, which will constitute a major asset restructuring but will not change the actual controller [7] Performance Forecasts - Limin Co. expects a net profit of 260 million to 280 million yuan for the first half of 2025, a year-on-year increase of 719.25% to 782.27% [9] - Zijin Mining anticipates a net profit of approximately 23.2 billion yuan for the first half of 2025, a year-on-year increase of about 54% [10] - Chunqiu Electronics forecasts a net profit of 9 million to 11 million yuan, an increase of 236.05% to 310.72% year-on-year [12] - Jinqilin expects a net profit of approximately 106 million yuan, a year-on-year increase of 222.36% [13] - Beihua Co. anticipates a net profit of 98 million to 111 million yuan, a year-on-year increase of 182.72% to 220.23% [14] - Guojin Securities expects a net profit of 1.092 billion to 1.137 billion yuan, a year-on-year increase of 140% to 150% [15] - Jiuyuan Silver Sea forecasts a net profit of 26.49 million to 32.25 million yuan, a year-on-year increase of 130% to 180% [16] - Lankai Technology expects a net profit of 1.1 billion to 1.2 billion yuan, a year-on-year increase of 85.5% to 102.36% [17] - Changcheng Securities anticipates a net profit of 1.335 billion to 1.407 billion yuan, a year-on-year increase of 85% to 95% [18] - Weilan Lithium Core expects a net profit of 300 million to 360 million yuan, a year-on-year increase of 79.29% to 115.15% [19] - Yinlong Co. forecasts a net profit of 161 million to 181 million yuan, a year-on-year increase of 60% to 80% [20] - Aopumai expects a net profit of approximately 37 million yuan, a year-on-year increase of 53.28% [22] - Bailong Dongfang anticipates a net profit of 350 million to 410 million yuan, a year-on-year increase of 50.21% to 75.97% [23] - Shanghai Electric expects a net profit of 1.754 billion to 2.087 billion yuan, a year-on-year increase of 32.18% to 57.27% [24] - Huazheng Securities reports a net profit of 1.035 billion yuan, a year-on-year increase of 44.94% [25] - Bailong Chuangyuan expects a net profit of 171 million yuan, a year-on-year increase of 42.68% [26] - Chengyi Pharmaceutical anticipates a net profit of 107 million to 119 million yuan, a year-on-year increase of 40% to 55% [27] - Jinhai Biological expects a net profit of 127 million to 141 million yuan, a year-on-year increase of 40% to 55% [28] - Kangda New Materials forecasts a net profit of 50 million to 55 million yuan, turning from loss to profit [29] - China Shenhua expects a net profit of 23.6 billion to 25.6 billion yuan, a year-on-year decrease of 8.6% to 15.7% [30] - ST Songfa anticipates a net profit of 580 million to 700 million yuan, turning from loss to profit [31] - Chengxing Co. expects a net profit of 16 million to 23 million yuan, turning from loss to profit [32] - Bofubang anticipates a net profit of 8 million to 12 million yuan, turning from loss to profit [33] - ST Yundong expects a loss of 100 million to 150 million yuan, an increase in loss compared to the previous year [34] - Kerryde expects a loss of 15 million to 22 million yuan, turning from profit to loss [35] Shareholding Changes - Defu Technology's shareholders plan to reduce their holdings by up to 4.04% [37] - Jinzhen Co.'s shareholders plan to reduce their holdings by up to 3.04% [38] - Shikong Technology's shareholder plans to reduce their holdings by up to 3% [39] - Qilu Bank's shareholder plans to reduce their holdings by up to 1.1% [40] - Zhongci Electronics' shareholder plans to reduce their holdings by up to 1% [41] - Jiamei Packaging's shareholders plan to reduce their holdings by up to 1% [42] - Saike Xide's shareholder plans to reduce their holdings by up to 1% [43] - Gongda High-Tech's general manager plans to reduce their holdings by up to 0.3424% [44] - Qingyuan Co.'s shareholder plans to reduce their holdings by up to 273,800 shares [45] Major Contracts - Dash Intelligent has been pre-awarded a procurement project worth 122 million yuan [46] - Robotech has signed significant daily operational contracts amounting to approximately 1.418 million USD [48]